CENTOGENE Announces Commencement of Testing for COVID-19
Cambridge, MA, USA & Rostock/Berlin, Germany, March 18, 2020 (Globe Newswire) – CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on […]
Cambridge, MA, USA & Rostock/Berlin, Germany, March 18, 2020 (Globe Newswire) – CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on […]
Cambridge, MA, USA and Rostock/Berlin, Germany, March 17, 2020 (Globe Newswire) – CENTOGENE N.V. (Nasdaq: CNTG), a commercial-stage company focused […]
On the occasion of International Rare Disease Day on February 29th, the Iberoamerican Alliance for Rare, Orphan, and Infectious Diseases […]
Cambridge, MA, USA & Rostock/Berlin, Germany, February 29, 2020 – CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases […]
On Saturday, February 29th, CENTOGENE, OMER, and ALIBER will celebrate International Rare Disease Day with an event for patients, healthcare […]
Cambridge, MA, USA & Rostock, Germany – February 25, 2020 – CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare […]
Cambridge, MA, USA and Rostock/Berlin, Germany, March 9, 2020 – CENTOGENE (Nasdaq: CNTG) ─ The Company today announced that Dr. […]
State-of-the-art Biorepository in Rostock, Germany is the first CAP-accredited repository outside the U.S. Cambridge, MA, USA & Rostock, Germany February […]
Supporting Patients for Accelerated Diagnosis and Treatment Development Cambridge, MA USA & Rostock, Germany December 13, 2019 – In an […]
Cambridge, MA USA & Rostock, Germany December 6, 2019 – CENTOGENE (Nasdaq: CNTG) today announced the expansion of its executive […]
ROSTOCK/BERLIN, Deutschland und CAMBRIDGE, MA, USA 21. November 2019 (GLOBE NEWSWIRE) – CENTOGENE (Nasdaq: CNTG), ein auf seltene Erkrankungen spezialisiertes […]
CAMBRIDGE, Mass. and ROSTOCK and BERLIN, Germany, November 21, 2019 (GLOBE NEWSWIRE) – CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused […]
Cambridge, MA, USA & Rostock, Berlin, GERMANY, 18 November 2019 – Centogene N.V. (NASDAQ: CNTG), a commercial-stage company focused on […]
Cambridge, MA, USA & Rostock/Berlin, GERMANY,13 November 2019 – CENTOGENE (Nasdaq: CNTG),commercial-stage company focused on rare diseases that transforms real-world clinical […]
Cambridge, MA, USA & Rostock, Berlin, GERMANY, 13 September 2019 – CENTOGENE today announced that Arndt Rolfs, Founder and CEO […]
